A combined immune and exosome-related risk signature as prognostic biomakers in acute myeloid leukemia.
Zenghui FangJiali FuXin ChenPublished in: Hematology (Amsterdam, Netherlands) (2024)
An immune-ERG-based risk model was developed to effectively predict prognostic outcomes for AML patients. There is potential for immune therapy in AML targeting the five hub genes.
Keyphrases
- acute myeloid leukemia
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- prognostic factors
- type diabetes
- genome wide
- bioinformatics analysis
- cancer therapy
- skeletal muscle
- adipose tissue
- metabolic syndrome
- dna methylation
- patient reported outcomes
- network analysis
- transcription factor
- smoking cessation
- drug induced